Home Shop Service Jobs Newsletter Company Sitemap Entertainment Shopping cart Deutsch
Books | Chemistry | Preclinical Safety Evaluation of Biopharmaceuticals
Browse our products
Books
 
Just published
Title search
Featured sites
Entertainment
Journals
Electronic Media
Choose your area of interest
 
Cavagnaro, Joy A. (ed.)
Preclinical Safety Evaluation of Biopharmaceuticals
A Science-Based Approach to Facilitating Clinical Trials

1. Edition - August 2008
139.- Euro
2008. 1064 Pages, Hardcover
- Monograph -
ISBN-10: 0-470-10884-3
ISBN-13: 978-0-470-10884-0 - John Wiley & Sons


Order



Sample Chapter

Short description
Proper preclinical safety evaluation can lessen the time and cost of launching new biopharmaceuticals and speed potentially life-saving drugs to market. This guide covers everything from lead candidate selection to establishing proof of concept and toxicity testing to the selection of the first human doses. With chapters contributed by experts in their specific areas, Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials:

* Includes an overview of biopharmaceuticals with information on regulation and methods of production
* Discusses the principles of ICH S6 and their implementation in the U.S., Europe, and Japan
* Covers current practices in preclinical development and includes a comparison of safety assessments for small molecules with those for biopharmaceuticals
* Addresses all aspects of the preclinical evaluation process, including: the selection of relevant species; safety/toxicity endpoints; specific considerations based upon class; and practical considerations in the design, implementation, and analysis of biopharmaceuticals
* Covers transitioning from preclinical development to clinical trials

This is a hands-on, straightforward reference for professionals involved in preclinical drug development, including scientists, toxicologists, project managers, consultants, and regulatory personnel.

From the contents
Foreword.

Acknowledgments.

Contributors.

Part I: Background.

Part II: Principles of Preclinical Development.

Part III: Current Practices in Preclinical Development.

Part IV: Selection of Relevant Species.

Part V: Safety/Toxicity Endpoints.

Part VI: Specific Considerations Based on Product Class.

Part VII: Preclinical Study Design, Implementation, and Analysis.

Part VIII: Transitioning From Preclinical Development to Clinical Trials.

Part IX: Afterword.

Index.


 
Order
Short description
Detailed description
Author information

Related Books

Encyclopedia of Drug Metabolism and Interactions
6-Volume Set

Parasitic Helminths
Targets, Screens, Drugs, and Vaccines

Apicomplexan Parasites
Molecular Approaches toward Targeted Drug Development


[more >>]

Related Journals

Angewandte Chemie

Angewandte Chemie International Edition

Chemie Ingenieur Technik


[more>>]

Special Offers

Christie, Daniel J. (ed.)

The Encyclopedia of Peace Psychology
385.- Euro
valid until
31 March 2012

[more offers >>]


 

        

Tell a friend          RSS Feeds             Print-Version

©2012 Wiley-VCH Verlag GmbH & Co. KGaA - Provider
http://www.wiley-vch.de - mailto: info@wiley-vch.de
Data Protection